Table 2.
Baseline of patients with differential LDL-C levels
| Factor | LDL-low n = 21 |
LDL-normal n = 29 |
LDL-high n = 11 |
P† |
|---|---|---|---|---|
| Sex | ||||
| Male | 16 (76.2) | 21 (72.4) | 6 (54.5) | 1.000/0.451 |
| Female | 5 (23.8) | 8 (27.6) | 5 (45.5) | |
| Age | ||||
| < 60 yr | 5 (23.8) | 11 (37.9) | 4 (36.4) | 0.365/1.000 |
| ≥ 60 yr | 16 (76.2) | 18 (62.1) | 7 (63.6) | |
| Tumor location | ||||
| Upper 1/3 | 4 (19.0) | 4 (13.8) | 1 (9.1) | 0.632/0.702 |
| Middle 1/3 | 5 (23.8) | 11 (37.9) | 6 (54.5) | |
| Lower 1/3 | 12 (57.1) | 14 (48.3) | 4 (36.4) | |
| Tumor size, cm | ||||
| < 3 cm | 5 (23.8) | 13 (44.8) | 3 (27.3) | 0.149/0.473 |
| ≥ 3 cm | 16 (76.2) | 16 (55.2) | 8 (72.7) | |
| Histologic differentiation | ||||
| Well | 2 (9.5) | 2 (6.9) | 0 | 1.000/0.855 |
| Moderate | 9 (42.9) | 13 (44.8) | 4 (36.4) | |
| Poor | 10 (47.6) | 14 (48.3) | 7 (63.6) | |
| T | ||||
| T1 | 3 (14.3) | 8 (27.6) | 2 (18.2) | 0.205/0.622 |
| T2 | 8 (38.1) | 7 (24.1) | 1 (9.1) | |
| T3 | 9 (42.9) | 8 (27.6) | 5 (45.5) | |
| T4 | 1 (4.8) | 6 (20.7) | 3 (27.3) | |
| N | ||||
| Negative | 9 (42.9) | 14 (48.3) | 4 (36.4) | 0.778/0.723 |
| Positive | 12 (57.1) | 15 (51.7) | 7 (63.6) | |
| M | ||||
| Negative | 21 (100.0) | 29 (100.0) | 11 (100.0) | - |
| Positive | 0 | 0 | 0 | |
| pStage | ||||
| I | 6 (28.6) | 11 (37.9) | 2 (18.2) | 0.770/0.459 |
| II | 10 (47.6) | 10 (34.5) | 4 (36.4) | |
| III | 5 (23.8) | 8 (27.6) | 5 (45.5) |
† LDL-low vs. LDL-normal / LDL-high vs. LDL-normal